Drewinko B, Yang L Y, Barlogie B
Cancer Res. 1982 Jan;42(1):107-11.
Cytotoxic and cytokinetic effects of 4'-(9-acridinylamino)methanesulfon-m-anisidine (m-AMSA) were studied on a cultured human colon carcinoma and on a human lymphoma (T1) cell line. Proliferating cells were more susceptible (10-fold) to the cytotoxic effect of m-AMSA than were nonproliferating cells. The agent had minimal effects on DNA synthesis. At comparable exposure doses on m-AMSA, the degree of lethal cell damage exceeded inhibition of DNA synthesis by 4-fold. Cells synchronized in different stages of the cell cycle were equally sensitive to the cytotoxic effects of the drug, although the major cytokinetic effect was a block in G2. A greater killing effect was obtained by fractionated delivery than by a comparable dose delivered at one. These results suggest that superior antitumor results may be achieved by adequately spaced low doses of m-AMSA in the treatment of sensitive human tumors.
研究了4'-(9-吖啶基氨基)甲磺基间茴香胺(m-AMSA)对培养的人结肠癌细胞和人淋巴瘤(T1)细胞系的细胞毒性和细胞动力学效应。增殖细胞比非增殖细胞对m-AMSA的细胞毒性作用更敏感(10倍)。该药物对DNA合成的影响最小。在m-AMSA的可比暴露剂量下,致死性细胞损伤程度比DNA合成抑制程度高4倍。在细胞周期不同阶段同步化的细胞对该药物的细胞毒性作用同样敏感,尽管主要的细胞动力学效应是在G2期阻滞。分次给药比一次性给予可比剂量产生更大的杀伤效果。这些结果表明,在治疗敏感的人类肿瘤时,通过适当间隔的低剂量m-AMSA可能会取得更好的抗肿瘤效果。